Dynamic Group Sales Manager with Pfizer Corporation, recognized for driving Eliquis to market leadership and achieving 100% growth for Nurtec. Expert in people management and strategic execution, fostering high-performing teams. Proven track record in overcoming market access challenges and enhancing sales revenue through innovative strategies and effective communication.
- Leading Eliquis to Entrench No.1 position in the NOACs market (HK$ 275M)
- Collaborating with marketing to develop Patient Support Program in Trade and NGOs to tackle generic erosion.
- Driving Nurtec's market growth (Migraine) , achieving 100% growth rate.
- Formulating KOLs engagement plan for facilitating Nurtec Special Drugs Submission from SFI through (CoC Medicine)
- Managing a diverse team of 15 professionals responsible for sales and market penetration across HA, Private sector and Trade markets.
- Increased group sales revenue by implementing strategic sales strategy and leading a high-performing sales team, fostering an environment of accountability that led to consistent target achievement in past 8 years for Eliquis, no.1 Brand in Pfizer.
- Drove growth for Eliquis from No.3 to Market Leader (HK$150M to HK$ 220M)
- Successfully navigated market access challenges in Atrial Fibrillation (AF) market and spearheaded Venous Thromboembolism (VTE) expansion via relaxed Special Drug (SD) criteria in HA formulary
- Collaborated cross-functionally with Market Access, Medical and Marketing partners to lobby HA formulary (SD) criteria relaxation through data publishing of Cancer-Associate Venous Thromboembolism (CA-VTE).
- Managed CV portfolio of Hypertension Franchise, Olmetec and Azoren (HK$ 40M)
- Developed a high-performing sales team of 15 Sales professionals covers HA and Private Markets through targeted recruitment, comprehensive training, and ongoing mentorship.
Sales Manager - Inflammation and Immunology
Marketing Secondment (2016)
- Drove market leader position for Enbrel in Rheumatoid Arthritis (RA) market under vigorous competition of the biologics market (HK$ 60M)
- Launched and enlisted Xeljanz in both HK and Macau Market
- Leaded a team of 5 people include one headcount in Macau
- Managed key accounts with strategic planning and relationship building, resulting in increased customer loyalty to defend the vigorous competition among 100 rheumatologist
- Rotated and Leaded sub-team in various Sales Team, Neuroscience/ Pain/ Anti-infective
(Effexor/ Lyrica/ Vfend/ Zyvox)
- Collaborated with Sales Manager to set sales targets and strategies, achieving consistent sales growth.
- Facilitated team-building activities, enhancing team cohesion and morale.
- People Management
- Problem Solving
- Communication
- Flawless Execution
2024 China President Award Winner